[
  {
    "ts": null,
    "headline": "Is It Too Late To Consider STERIS (STE) After Its Strong 1 Year Share Price Return?",
    "summary": "Some investors may be wondering whether STERIS at around US$259.87 is offering good value right now, or if the recent price puts it on the expensive side. The stock has been fairly steady over the last week with a 0.1% decline, while the 1 year return of 26.5% and 5 year return of 44.3% may catch the eye of investors watching longer term performance. Recent attention on STERIS has focused on its role as a healthcare equipment and services provider, and how the market is pricing that exposure...",
    "url": "https://finnhub.io/api/news?id=a17b22facac0a3764d428c287138cd8b63bc3c23eacff08d125a6d06a997d6d8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768417747,
      "headline": "Is It Too Late To Consider STERIS (STE) After Its Strong 1 Year Share Price Return?",
      "id": 138114899,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "STE",
      "source": "Yahoo",
      "summary": "Some investors may be wondering whether STERIS at around US$259.87 is offering good value right now, or if the recent price puts it on the expensive side. The stock has been fairly steady over the last week with a 0.1% decline, while the 1 year return of 26.5% and 5 year return of 44.3% may catch the eye of investors watching longer term performance. Recent attention on STERIS has focused on its role as a healthcare equipment and services provider, and how the market is pricing that exposure...",
      "url": "https://finnhub.io/api/news?id=a17b22facac0a3764d428c287138cd8b63bc3c23eacff08d125a6d06a997d6d8"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Retain TransMedics Stock in Your Portfolio for Now",
    "summary": "TMDX gains momentum as OCS technology, a robust pipeline and strong Q3 results fuel growth, though gross margin pressure tempers the outlook.",
    "url": "https://finnhub.io/api/news?id=62a6eb7e86e65b341cc1db72c322ed960ef43ab9106bc6bb4634fcf6605b62ee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768405680,
      "headline": "Reasons to Retain TransMedics Stock in Your Portfolio for Now",
      "id": 138113253,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "STE",
      "source": "Yahoo",
      "summary": "TMDX gains momentum as OCS technology, a robust pipeline and strong Q3 results fuel growth, though gross margin pressure tempers the outlook.",
      "url": "https://finnhub.io/api/news?id=62a6eb7e86e65b341cc1db72c322ed960ef43ab9106bc6bb4634fcf6605b62ee"
    }
  },
  {
    "ts": null,
    "headline": "Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety",
    "summary": "BAX introduces its Dynamo Series smart stretcher, aiming to boost hospital safety and reduce patient transfers.",
    "url": "https://finnhub.io/api/news?id=b89aaa164d39860cc73a5515dc49703a7c4f661d1a3189aed41cb83fb458a97b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768405440,
      "headline": "Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety",
      "id": 138113254,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "STE",
      "source": "Yahoo",
      "summary": "BAX introduces its Dynamo Series smart stretcher, aiming to boost hospital safety and reduce patient transfers.",
      "url": "https://finnhub.io/api/news?id=b89aaa164d39860cc73a5515dc49703a7c4f661d1a3189aed41cb83fb458a97b"
    }
  }
]